Health Bulletin 24/December/2021

Here are Top Health stories of the day

Doctors Indemnity Not For Hospital: Supreme Court

The Supreme Court has recently observed that if a hospital is not the beneficiary of the insurance policies, which have been obtained by doctors to cover the discharge of their own professional negligence, a joint and several liabilities could not be fastened on the insurer to cover the claims made to a hospital.

Upholding the order of the NCDRC, the Apex court bench comprising of Justices DY Chandrachud and AS Bopanna noted, "The hospital was not the beneficiary of the insurance policies which were obtained by the doctors to cover the discharge of their own professional obligations. There was a manifest error on the part of the District Forum as well as the State Commission. The NCDRC had a valid basis to exercise its revisional jurisdiction."

For more details, check out the full story on the link below:

Doctors Indemnity not for Hospital: Supreme Court 

No Faculty In 5 Departments: NMC Inspection Points Out Faculty Shortage At Dumka Medical College

Although it has been three months since the National Medical Commission (NMC) has given its nod for 100 MBBS seats at Dumka-based Phulo Jhano Medical College, in a recent inspection by a National Medical Commission (NMC) member, the Commission has found out faculty shortage in the College.

The NMC inspector has noted down that there is not a single faculty in five departments of the college including Biochemistry, Pharmacology, Radiology, Skin, and Anaesthesia. Further, there is an acute shortage of faculty members in several other departments as well.

For more details, check out the full story on the link below:

No Faculty In 5 Departments: NMC Inspection Points Out Faculty Shortage At Dumka Medical College

Covishield Protection Diminishes After 3 Months: Lancet Study 

The protection offered by the Oxford-Astra Zeneca COVID-19 vaccine declines after three months of receiving two doses of the preventive, according to a study published in The Lancet journal.

The findings drawn from datasets in Brazil and Scotland suggest that booster programmes are needed to help maintain protection from severe disease in those vaccinated with AstraZeneca, known as Covishield in India.

For more details, check out the full story on the link below:

Covishield protection diminishes after 3 months: Lancet study 

India's Omicron Cases Rise To 358 With 122 In Last 24 Hours 

India recorded 122 cases of the Omicron variant of COVID-19 in a span of 24 hours, the highest so far, pushing its tally in the country to 358, 114 of which have recovered or migrated, according to Union Health Ministry data updated on Friday.

Finally Molnupiravir Gets USFDA Nod

A day after Pfizer's Paxlovid bagged the U.S. Food and Drug Administration (USFDA) Emergency Use Authorization (EUA) nod, Merck's much awaited COVID-19 oral antiviral has also been given the authority's EUA approval

Merck and Ridgeback Biotherapeutics late last night announced that the U.S. Food and Drug Administration (USFDA) has granted Emergency Use Authorization (EUA) for molnupiravir, an investigational oral antiviral (MK-4482, EIDD-2801).

For more details, check out the full story on the link below:

Finally Molnupiravir gets USFDA nod

FIR Against 3 SMS Hospital Doctors For Allegedly Molesting Colleague At Workplace

 An FIR has been filed against three doctors attached to SMS Hospital for allegedly sexually harassing their colleague, a 53-year-old woman doctor at workplace.

A case under Section 354 (Assault or criminal force to woman with intent to outrage her modesty) of the IPC has been filed against the trio including a senior doctor of the victim's department, a female doctor and a medical student undergoing post-graduation.

For more details, check out the full story on the link below:

FIR Against 3 SMS Hospital Doctors For Allegedly Molesting Colleague At Workplace